Calprotectin and Gut Health in Newborns with Heart Disease
Part of Digestive system, Genetic & congenital, Heart & circulation clinical trials.
This study looks at a substance called calprotectin, which is a marker of inflammation in the gut. It aims to understand gut health in very young babies who have serious heart conditions and need treatment soon after birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be 3 months old or younger at the time of joining.
- Your baby has a major heart defect that requires early surgery or a heart procedure.
- Your baby is currently being treated in a specialist heart centre with breathing support or medicines to support their heart and blood pressure.
- Your baby does not have any gut problems like gastroschisis (a hole in the belly) or imperforate anus.
- Your baby does not have a condition called neutropenia (low levels of a certain white blood cell).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children with severe heart problems born recently to see how their brain development progresses. It helps doctors understand what support these children might need as they grow.
This study measures how well blood flows to the brain in infants with serious heart defects. The results may help doctors understand and protect brain development before and after heart surgery.
This study is looking at a protein called calprotectin in the stool of babies and young children with Hirschsprung's disease. The goal is to see if it can help detect a serious gut inflammation called enterocolitis earlier.
This study looks at gut health in pregnant women with and without inflammatory bowel disease (IBD). It tracks a protein called calprotectin in stool samples, along with diet and baby health, to learn how IBD affects pregnancy and infant development.
This study looks at how the gut works and what bacteria are in it for very early babies born at 24 to 32 weeks. It aims to understand gut health better to help improve care.
This study uses ultrasound to measure how a newborn's heart pumps during serious blood infections (sepsis). Researchers want to understand how sepsis affects heart function in babies, which may help doctors treat newborns better.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.